A population-based, case–control study of green tea consumption and leukemia risk in southwestern Taiwan
- 28 August 2008
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 20 (1) , 57-65
- https://doi.org/10.1007/s10552-008-9217-7
Abstract
Objective This study investigated the association between green tea consumption and leukemia. Methods A total of 252 cases (90.3% response) and 637 controls (53.4% response) were enrolled. Controls were matched for cases on age and gender. Information was collected on participants’ living habits, including tea consumption. Green tea was used as a standard to estimate the total amount of individual catechin consumption. We stratified individual consumption of catechins into four levels. Conditional logistic regression models were fit to subjects aged 0–15 and 16–29 years to evaluate separate associations between leukemia and catechin consumption. Results A significant inverse association between green tea consumption and leukemia risk was found in individuals aged 16–29 years, whereas no significant association was found in the younger age groups. For the older group with higher amounts of tea consumption (>550 units of catechins), the adjusted odds ratio (OR) compared with the group without tea consumption was 0.47 [95% confidence interval (CI) = 0.23–0.97]. After we adjusted for smoking status and medical irradiation exposure, the overall OR for all participants was 0.49 (95% CI = 0.27–0.91), indicating an inverse relation between large amounts of catechins and leukemia. Conclusion Drinking sufficient amounts of tea, especially green tea, which contains more catechins than oolong tea and black tea, may reduce the risk of leukemia.Keywords
This publication has 33 references indexed in Scilit:
- Diet and the risk of gastric cancer: review of epidemiological evidenceGastric Cancer, 2007
- Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese populationEuropean Journal of Gastroenterology & Hepatology, 2007
- Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinomaMolecular Cancer Therapeutics, 2006
- Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cellsMolecular Cancer Therapeutics, 2006
- Tea drinking and the risk of biliary tract cancers and biliary stones: A population‐based case–control study in Shanghai, ChinaInternational Journal of Cancer, 2006
- Green Tea Component, Catechin, Induces Apoptosis of Human Malignant B Cells via Production of Reactive Oxygen SpeciesClinical Cancer Research, 2005
- Delineation of antimutagenic activity of catechin, epicatechin and green tea extractMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Green tea: prevention and treatment of cancer by nutraceuticalsThe Lancet, 2004
- Green tea and cancer in humans: A review of the literatureNutrition and Cancer, 1998
- Relationship between antimutagenic activity and major components of various teasMutagenesis, 1996